NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract, and other CK7+ carcinomas: potential use for determining site of origin.

Source:http://linkedlifedata.com/resource/pubmed/id/21846919

Download in:

View as

General Info

PMID
21846919